Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1

Status

Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2Gynecologic 2

Conditions

Endometrial Neoplasms 20Endometrial Hyperplasia 7Overweight 2Obesity 2Turcot syndrome 1Squamous Intraepithelial Lesions 1Recurrence 1Neoplasms 1Mesothelioma, Malignant 1Infertility 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Carcinoma, Endometrioid 1Breast Neoplasms 1

Interventions

Tirzepatide 3Methods 3Surveys and Questionnaires 2Resistance Training 2Progestins 2Nutrition Assessment 2Megestrol Acetate 2semaglutide 1atezolizumab 1Yoga 1Therapeutics 1Tablets 1TIC10 compound 1Sampling Studies 1Psychology, Positive 1Patient Navigation 1Neuroimaging 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1Letrozole 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Hysteroscopy 1Estrogen Replacement Therapy 1Early Intervention, Educational 1Diet, Mediterranean 1Diet Therapy 1Counseling 1Body Weight Maintenance 1Blood Specimen Collection 1Blood Glucose Self-Monitoring 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Obesity × Megestrol Acetate × Gynecologic × Clear all
NCT05316467 2026-06-04

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

Fudan University

Phase 2/3 Terminated
8 enrolled
GynecologicOther

Infertility, Obesity, Endometrial Neoplasms, Overweight

NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡